Air, Express, Freight News, Logistics

Healthy growth for UPS

[ October 6, 2021   //   ]

UPS Healthcare’s clinical trial logistics arm has expanded its network for specialist logistics company Marken to support increased demand for cell and gene clinical trials.

The program adds over 100,000sq ft of GMP-compliant depot operations in Louisville, KY, Great Valley, PA, and Seoul, South Korea.

There are new depots  in Kiev, Ukraine and Osaka, Japan along with new locations in Nairobi, Kenya and Accra, Ghana.

Marken is also expanding its kit assembly facility in Shanghai, and has added liquid nitrogen filling stations within each of its global cell and gene  centres of excellence

Marken president Ariette van Strien said: “We are accelerating the expansion of our clinical supply chain network across all regions to provide increased flexibility and global access for our partners, including access in emerging markets like South Korea and Sub-Saharan Africa. These investments are especially critical for cell and gene therapy developers, where we see increased innovation. With the FDA expecting to approve 10 to 20 cell and gene therapy products per year by 2025, our industry-leading network is designed to simplify the transition from clinical trials to commercialization.”

Marken has also set up a track and trace control centre at its Ukraine facility which, combined with the existing control  centre in Durham, NC, US, will enhance global monitoring of all complex shipments, including cell and gene shipments.